![Cynthia Mandjek](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cynthia Mandjek
Investitore di Private Equity presso Saviu Ventures Ltd.
Profilo
Cynthia Mandjek is currently working as a Principal at Saviu Ventures Ltd.
She previously worked as the Chief Executive Officer and Chief Operating Officer at Aqemia SAS.
Ms. Mandjek completed her undergraduate degree at Saint Louis College in 2013 and her graduate degree at ESCP Business School in 2017.
Posizioni attive di Cynthia Mandjek
Società | Posizione | Inizio |
---|---|---|
Saviu Ventures Ltd.
![]() Saviu Ventures Ltd. Investment ManagersFinance Saviu Ventures Ltd (Saviu Ventures) is a venture capital firm founded in 2017 by Benoit Delestre and Arthur Thuet. The firm is headquartered in Nairobi, Kenya. | Investitore di Private Equity | 01/03/2021 |
Precedenti posizioni note di Cynthia Mandjek
Società | Posizione | Fine |
---|---|---|
Aqemia SAS
![]() Aqemia SAS Packaged SoftwareTechnology Services Aqemia SAS develops software to predict the affinity between drug candidates and therapeutic targets responsible for diseases. The company was founded by Emmanuelle Martiano Rolland and Maximilien Levesque in 2019 and is headquartered in Paris, France. | Amministratore Delegato | 01/03/2021 |
Formazione di Cynthia Mandjek
Escp Business School | Graduate Degree |
Saint Louis College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Saviu Ventures Ltd.
![]() Saviu Ventures Ltd. Investment ManagersFinance Saviu Ventures Ltd (Saviu Ventures) is a venture capital firm founded in 2017 by Benoit Delestre and Arthur Thuet. The firm is headquartered in Nairobi, Kenya. | Finance |
Aqemia SAS
![]() Aqemia SAS Packaged SoftwareTechnology Services Aqemia SAS develops software to predict the affinity between drug candidates and therapeutic targets responsible for diseases. The company was founded by Emmanuelle Martiano Rolland and Maximilien Levesque in 2019 and is headquartered in Paris, France. | Technology Services |
- Borsa valori
- Insiders
- Cynthia Mandjek